Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT03175172
Title Evaluation of CRS-207 With Pembrolizumab in Previously Treated MPM
Recruitment Terminated
Gender both
Phase Phase II
Variant Requirements No
Sponsors Aduro Biotech, Inc.
Indications
Therapies
Age Groups: senior | adult
Covered Countries USA

Facility Status City State Zip Country Details
UCSF Comprehensive Cancer Center San Francisco California 94115 United States Details
H. Lee Moffitt Cancer Center Tampa Florida 33612 United States Details
University of Chicago Medical Center Chicago Illinois 60637 United States Details
NIH National Cancer Institute Bethesda Maryland 20892 United States Details
Mayo Clinic Rochester Minnesota 55905 United States Details
Laura & Isaac Perlmutter Cancer Center at NYU Langone New York New York 10016 United States Details
Cleveland Clinic Foundation Cleveland Ohio 44195 United States Details
Abramson Cancer Center of the University of Pennsylvania Philadelphia Pennsylvania 19104 United States Details
*Shaded cells indicate that there was no data available from clincialtrials.gov for the field